Ladenburg Thalmann cut shares of CONMED (NASDAQ
:CNMD) from a buy rating to a neutral rating in a research note issued to investors on Friday,TheFlyOnTheWall.com reports. The firm currently has $55.00 price target on the stock.
A number of other firms have also recently commented on CNMD. Analysts at Piper Jaffray reiterated a hold rating and set a $51.00 price target (up previously from $47.00) on shares of CONMED in a research note on Thursday. Analysts at Needham & Company LLC raised their price target on shares of CONMED from $54.00 to $56.00 and gave the company a buy rating in a research note on Thursday. Analysts at Zacks reiterated a sell rating and set a $45.00 price target on shares of CONMED in a research note on Friday, March 27th. Finally, analysts at KeyBanc initiated coverage on shares of CONMED in a research note on Monday, March 16th. They set a sector weight rating on the stock. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $53.83.
